Georgetown University

🇬🇹Guatemala

Country: 🇬🇹Guatemala

Ownership: Private

Established: 1789-01-23

Employees: 5K

Market Cap: -

Website: http://www.georgetown.edu

Clinical Trials

Multimodal Perioperative Pain Management: ComfortSafe Program

Conditions: Post-operative Nausea and Vomiting
Respiratory Depression
Confusion Postoperative
Post-operative Pain

First Posted Date: 2019-08-06

Last Posted Date: 2020-10-05

Lead Sponsor: Georgetown University

Target Recruit Count: 60

Registration Number: NCT04046068

Locations: 🇺🇸
Medstar Georgetown University Hospital, Washington, District of Columbia, United States

NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer

Phase 2

Recruiting

Conditions: Advanced Biliary Tract Cancer

Interventions: Drug: Nanoliposomal Irinotecan
Drug: Leucovorin
Drug: Fluorouracil

First Posted Date: 2019-07-02

Last Posted Date: 2023-12-22

Lead Sponsor: Georgetown University

Target Recruit Count: 44

Registration Number: NCT04005339

Locations: 🇺🇸
Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, United States
🇺🇸
Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States
🇺🇸
Washington University School of Medicine- Siteman Cancer Center, Saint Louis, Missouri, United States

and more 1 locations

Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Dementia With Lewy Bodies

Phase 2

Recruiting

Conditions: Dementia With Lewy Bodies

Interventions: Drug: Placebo oral capsule
Drug: Nilotinib Oral Capsule

First Posted Date: 2019-06-28

Last Posted Date: 2023-05-15

Lead Sponsor: Georgetown University

Target Recruit Count: 60

Registration Number: NCT04002674

Locations: 🇺🇸
MedStar Georgetown University Hospital, Washington, District of Columbia, United States

K0706 for Patients Diagnosed With Dementia With Lewy Bodies

Phase 2

Recruiting

Conditions: Dementia With Lewy Bodies

Interventions: Drug: Placebo
Drug: 192 mg powder of K0706
Drug: 384 mg powder of K0706

First Posted Date: 2019-06-24

Last Posted Date: 2022-10-19

Lead Sponsor: Georgetown University

Target Recruit Count: 45

Registration Number: NCT03996460

Locations: 🇺🇸
MedStar Georgetown University Hospital, Washington, District of Columbia, United States

TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer

Phase 1

Active, not recruiting

Conditions: Breast Cancer

Interventions: Drug: Talazoparib
Drug: Avelumab

First Posted Date: 2019-05-28

Last Posted Date: 2024-04-24

Lead Sponsor: Georgetown University

Target Recruit Count: 24

Registration Number: NCT03964532

Locations: 🇺🇸
University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, United States
🇺🇸
MedStar Georgetown University Hospital, Washington, District of Columbia, United States

Testing a Culturally Adapted Telephone Genetic Counseling Intervention

Not Applicable

Completed

Conditions: Hereditary Breast Cancer
Breast Cancer

Interventions: Behavioral: Telephone Genetic Counseling

First Posted Date: 2019-05-22

Last Posted Date: 2021-09-01

Lead Sponsor: Georgetown University

Target Recruit Count: 37

Registration Number: NCT03959267

Locations: 🇺🇸
Nueva Vida, Alexandria, Virginia, United States
🇺🇸
Capital Breast Care Center, Washington, District of Columbia, United States
🇺🇸
Hackensack Meridian Health, Hackensack, New Jersey, United States

and more 1 locations

Metta Meditation Training on Prosocial Behavior

Not Applicable

Completed

Conditions: Social Behavior

Interventions: Behavioral: Metta meditation

First Posted Date: 2019-03-29

Last Posted Date: 2021-06-16

Lead Sponsor: Georgetown University

Target Recruit Count: 67

Registration Number: NCT03894930

Locations: 🇺🇸
Georgetown University, Washington, District of Columbia, United States

Impact of Bosutinib on Safety, Tolerability, Biomarkers and Clinical Outcomes in Dementia With Lewy Bodies

Phase 2

Completed

Conditions: Dementia With Lewy Bodies

Interventions: Drug: Placebo Oral Tablet
Drug: Bosutinib Oral Tablet

First Posted Date: 2019-03-25

Last Posted Date: 2022-04-05

Lead Sponsor: Georgetown University

Target Recruit Count: 26

Registration Number: NCT03888222

Locations: 🇺🇸
MedStar Georgetown University Hospital, Washington, District of Columbia, United States

Study of Proton Therapy in Adjuvant Pancreatic Cancer

Phase 1

Completed

Conditions: Resected Pancreatic Adenocarcinoma

Interventions: Drug: mFOLFIRINOX
Radiation: Proton beam radiation

First Posted Date: 2019-03-21

Last Posted Date: 2024-10-24

Lead Sponsor: Georgetown University

Target Recruit Count: 9

Registration Number: NCT03885284

Locations: 🇺🇸
Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States

WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor

Phase 1

Active, not recruiting

Conditions: Metastatic Breast Cancer
Hormone Receptor Positive Breast Cancer
Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Interventions: Drug: Palbociclib
Drug: Bosutinib
Drug: Fulvestrant

First Posted Date: 2019-02-26

Last Posted Date: 2023-12-21

Lead Sponsor: Georgetown University

Target Recruit Count: 19

Registration Number: NCT03854903

Locations: 🇺🇸
Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy